Inhibition by mepacrine and p-bromophenacylbromide of phosphoinositide hydrolysis, glucose oxidation, calcium uptake and insulin release in rat pancreatic islets.
Inhibition by mepacrine and p-bromophenacylbromide of phosphoinositide hydrolysis, glucose oxidation, calcium uptake and insulin release in rat pancreatic islets.
复制标题
Mepacrine 和对溴苯甲酰溴对大鼠胰岛中磷酸肌醇水解、葡萄糖氧化、钙摄取和胰岛素释放的抑制作用。
DOI:
10.1016/0006-2952(84)90641-5
复制
发表时间:
1984
影响因子:
5.8
通讯作者:
W. Malaisse
中科院分区:
文献类型:
--
作者:
L. Best;A. Sener;P. Mathias;W. Malaisse
Mepacrine andp-bromophenacylbromide were both found to impair3H-inositol phosphate production in response to both nutrient and hormone-neurotransmitter stimuli in islets prelabelled with3H-inositol. Both drugs also inhibited net45Ca uptake in response to glucose or glibenclamide and considerably modified the patterns of45Ca and86Rb efflux from perifused islets under both basal and glucose-stimulated conditions. In addition, the oxidation of [U-14C] glucose in islets was impaired by either mepacrine orp-bromophenacylbromide. These inhibitory effects were found to be concentration-related for both mepacrine (0.01–1.0 mM) andp-bromophenacylbromide (0.03–0.3 mM) and were accompanied, in general, by a similar degree of inhibition of insulin secretion. These results suggest that both mepacrine andp-bromophenacylbromide can inhibit phospholipase C activity in intact islets, but also impair45Ca and86Rb fluxes and oxidation of nutrients. The diversity of these drugs' inhibitory actions makes them unsuitable tools for examining the role of specific cellular processes in the regulation of islet function.
影响因子:
3.9
作者:
Hofmann,SL;Prescott,SM;Majerus,PW
通讯作者:
Majerus,PW